*Ein kleiner Tipp: Wenn du unten im Video auf das Zahlenrad klickst, kannst du die Geschwindigkeit des Videos erhöhen oder auch verlangsamen.
Das erfährst du in diesem Video (Minutenangaben zum Vorspulen)...
2:47 Informationen zum Thema mehr Energie, weniger Erschöpfung und Müdigkeit und zum Fettstoffwechsel
6:18 Chronique Fatigue Syndrom (CFS)
8:37 Erschöpfung bei Krebs
9:18 Multiple Sklerose (MS)
10:43 Schilddrüsenunterfunktion und Schilddrüsenüberfunktion (Morbus Basedow, Hashimoto)
13:40 Muskelschwäche und Muskelschmerzen (z.B. durch Schilddrüsenerkrankungen, Krebs, Nierenerkrankungen)
15:40 Einsatz beim Sport (Regeneration, Fettverbrennung, Krämpfe etc.)
16:40 Herz-Kreislauf-Gesundheit: Herzmuskelschwäche, Angina Pectoris, Bluthochdruck, Herzinsuffizienz, koronare Herzkrankheit, Arrhythmien, Herzinfarkt, Schaufensterkrankheit, Blutfettwerte, Cholesterin, Triglyceride
20:40 Unterstützung beim Abnehmen
22:20 Alterserscheinungen, gesundes Altern
23:50 Diabetes Typ 1 und 2
24:50 Insulinresistenz (bei Diabetes, Autoimmunerkrankungen, Krebserkrankungen, Herz-Kreislauferkrankungen, Entzündungen)
27:50 Oxidativer Stress, freie Radikale, Antioxidantien (z.B. bei Autoimmunerkrankungen oder Krebs)
29:30 Krebs
31:00 Nierenerkrankungen
31:48 Lebergesundheit: Fettleber, Entgiftung
32:50 Immunsystem, Infektanfälligkeit
34:00 Hirn- und Denkleistung, Gedächtnis, Aufmerksamkeit, Alkoholabhängigkeit
35:20 Alzheimer, Parkinson
36:00 Depressionen (auch bei Fibromyalgie und hepatischer Enzephalopathie)
37:50 Fruchtbarkeit
Ausschnitt der im Video erwähnten Studien und Quellen:
Arrigoni-Martelli E, Caso V. Carnitine protects mitochondria and removes toxic acyls from xenobiotics. Drugs Exp Clin Res, 2001; 27(1):27 – 49.
Plioplys S, Plioplys A V, Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome, https://pubmed.ncbi.nlm.nih.gov/9018019/
Cruciani RA et al. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis. Ann NY Acad Sci 2004;1033:168-76.
Maruyama T et al. Efficacy of L-carnitine supplementation for improving lean body mass and physical function in patients on hemodialysis: a randomized controlled trial. Eur J Clin Nutr. 2019;73(2):293-301. doi:10.1038/s41430-018-0348-y
Sayed-Ahmed MM. Role of carnitine in cancer chemotherapy-induced multiple organ toxicity. Saudi Pharm J. 2010 Oct;18(4):195-206.
Kraemer W J et al. The effects of L-carnitine L-tartrate supplementation on hormonal responses to resistance exercise and recovery.
Volek J S et al. L-Carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress.
Xiaolong, Song. et al. (2017): Efficacy and Safety of L-Carnitine Treatment for Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Biomed Res Int. 2017; 2017: 6274854.
Kamikawa T et al. Effects of L-carnitine on exercise tolerance in patients with stable angina pectoris. Jpn Heart J 1984;25:587-597.
Canale C et al. Bicycle ergometer and echocardiographic study in healthy subjects and patients with angina pectoris after administration of L-carnitine: semiautomatic computerized analysis of M-mode tracing. Int J Clin Pharmacol Ther Toxicol 1988;26:221-224.
Cherchi A et al. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study. Int J Clin Pharmacol Ther Toxicol 1985;23:569-572.
Spielring B A et al. Effects of L-carnitine L-tartrate supplementation on muscle oxygenation responses to resistance exercise.
Giamberardino M A et al. Effects of prolonged L-carnitine administration on delayed muscle pain and CK release after eccentric effort.
Miguel-Carrasco J L et al. The role of inflammatory markers in the cardioprotective effect of L-carnitine in L-NAME-induced hypertension.
Arsenian M A. Carnitine and its derivatives in cardiovascular disease.
Ferrari R et al. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Iliceto S et al. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction.
Hiatt WR. Carnitine and peripheral arterial disease. Ann NY Acad Sci 2004;1033:92-8.
Tarantini G et al. Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial. Cardiology 2006;106:215-23.
DiNicolantonio JJ et al. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc 2013;88:544-51.
Malaguarnera M et al. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr. 2009 Jan;89(1):716. https://www.ncbi.nlm.nih.gov/pubmed/19056606
Najafi, M. et al. Antiarrhythmic and arrhythmogenic effects of L-carnitine in ischemia and reperfusion. Bull Exp Biol Med. 2008 Aug;146(2):2103.
Pooyandjoo M et al. The effect of (L-)carnitine on weight loss in adults: a systematic review and meta-analysis of randomized controlled trials.
Askarpour M et al. Beneficial effects of l-carnitine supplementation for weight management in overweight and obese adults: An updated systematic review and dose-response meta-analysis of randomized controlled trials.
Malaguarnera M et al. L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial.
Malaguarnera M et al. Serum Carnitine Levels in Centenarians.
Fisher J S et al. Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin.
An J H et al. L-carnitine supplementation for the management of fatigue in patients with hypothyroidism on levothyroxine treatment: a randomized, double-blind, placebo-controlled trial.
Benvenga S et al. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial.
Molfino A et al. Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism.
Galloway S D R et al. Effects of oral L-carnitine supplementation on insulin sensitivity indices in response to glucose feeding in lean and overweight/obese males.
Lohninger A et al. Relationship between carnitine, fatty acids and insulin resistance
Rahbar A R et al. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus.
Ribas G S et al. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
Li N, Zhao H. Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update.
Gülcin I. Antioxidant and antiradical activities of l-carnitine.
Kitano Y et al. Oral administration of l-carnitine improves the clinical outcome of fertility in patients with IVF treatment. Gynecol Endocrinol. 2018;34(8):684-688. doi:10.1080/09513590.2018.1431769
Lenzi A et al. Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial.
Agarwal A et al. Role of L-carnitine in female infertility. Reprod Biol Endocrinol. 2018 Jan 26;16(1):5.
© 2024 | Medumio - Wissen, was hilft. Wissen, das hilft.